51 - 60 out of 136Page size: 10
  1. 2020

  2. Pathological validation and prognostic potential of quantitative MRI in the characterization of pancreas cancer: preliminary experience

    Klaassen, R., Steins, A., Gurney-Champion, O. J., Bijlsma, M. F., van Tienhoven, G., Engelbrecht, M. R. W., van Eijck, C. H. J., Suker, M., Wilmink, J. W., Besselink, M. G., Busch, O. R., de Boer, O. J., van de Vijver, M. J., Hooijer, G. K. J., Verheij, J., Stoker, J., Nederveen, A. J. & van Laarhoven, H. W. M., 1 Sept 2020, In: Molecular oncology. 14, 9, p. 2176-2189 14 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets

    le Large, T. Y., Mantini, G., Meijer, L. L., Pham, T. V., Funel, N., van Grieken, N. C., Kok, B., Knol, J., van Laarhoven, H. W., Piersma, S. R., Jimenez, C. R., Kazemier, G., Giovannetti, E. & Bijlsma, M. F., 6 Aug 2020, In: JCI insight. 5, 15, e138290.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types

    van den Ende, T., van den Boorn, H. C. G., Hoonhout, N. M., van Etten-Jamaludin, F. S., Meijer, S. L., Derks, S., de Gruijl, T. D., Bijlsma, M. F., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Aug 2020, In: BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. 1874, 1, 188386.

    Research output: Contribution to journal › Review article › Academic › peer-review

  5. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1

    Steins, A., van Mackelenbergh, M. G., van der Zalm, A. P., Klaassen, R., Serrels, B., Goris, S. G., Kocher, H. M., Waasdorp, C., de Jong, J. H., Tekin, C., Besselink, M. G., Busch, O. R., van de Vijver, M. J., Verheij, J., Dijk, F., van Tienhoven, G., Wilmink, J. W., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 6 May 2020, In: EMBO reports. 21, 5, e48780.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach

    le Large, T. Y. S., Meijer, L. L., Paleckyte, R., Boyd, L. N. C., Kok, B., Wurdinger, T., Schelfhorst, T., Piersma, S. R., Pham, T. V., van Grieken, N. C. T., Zonderhuis, B. M., Daams, F., van Laarhoven, H. W. M., Bijlsma, M. F., Jimenez, C. R., Giovannetti, E. & Kazemier, G., 1 Apr 2020, In: oncologist. 25, 4, p. e634-e643

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma

    Steins, A., Klaassen, R., Jacobs, I., Schabel, M. C., van Lier, M. G. J. T. B., Ebbing, E. A., Hectors, S. J., Tas, S. W., Maracle, C. X., Punt, C. J. A., Siebes, M., Bergman, J. J. G. H. M., Medema, J. P., Wilmink, J. W., Mathot, R. A. A., Strijkers, G. J., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Apr 2020, In: Molecular oncology. 14, 4, p. 704-720 17 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Matrix metalloproteases in pancreatic ductal adenocarcinoma: Key drivers of disease progression?

    Slapak, E. J., Duitman, J., Tekin, C., Bijlsma, M. F. & Spek, C. A., Apr 2020, In: Biology. 9, 4, 80.

    Research output: Contribution to journal › Review article › Academic › peer-review

  9. Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma

    Strijker, M., Soer, E. C., de Pastena, M., Creemers, A., Balduzzi, A., Beagan, J. J., Busch, O. R., van Delden, O. M., Halfwerk, H., van Hooft, J. E., van Lienden, K. P., Marchegiani, G., Meijer, S. L., van Noesel, C. J., Reinten, R. J., Roos, E., Schokker, S., Verheij, J., van de Vijver, M. J., Waasdorp, C., & 6 othersWilmink, J. W., Ylstra, B., Besselink, M. G., Bijlsma, M. F., Dijk, F. & van Laarhoven, H. W., 1 Mar 2020, In: International journal of cancer. Journal international du cancer. 146, 5, p. 1445-1456 12 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study

    Stroes, C. I., Schokker, S., Creemers, A., Molenaar, R. J., Hulshof, M. C. C. M., van der Woude, S. O., Bennink, R. J., Mathôt, R. A. A., Krishnadath, K. K., Punt, C. J. A., Verhoeven, R. H. A., van Oijen, M. G. H., Creemers, G-J., Nieuwenhuijzen, G. A. P., van der Sangen, M. J. C., Beerepoot, L. V., Heisterkamp, J., Los, M., Slingerland, M., Cats, A., & 5 othersHospers, G. A. P., Bijlsma, M. F., van Berge Henegouwen, M. I., Meijer, S. L. & van Laarhoven, H. W. M., 10 Feb 2020, In: Journal of clinical oncology. 38, 5, p. 462-471 10 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. 2019

  12. A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue

    Lenos, K. J., Lodestijn, S. C., Lyons, S. K., Bijlsma, M. F., Miedema, D. M. & Vermeulen, L., Sept 2019, In: Nature protocols. 14, 9, p. 2648-2671

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 12 3 4 5 6 7 8 9 ...14 Next

ID: 41996